English
简体中文
Total: £ 56.28
Published Date: 2024-03-29 | Pages: 73 | Tables: 143 | Medical Care
The global Antimania Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antimania Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimania Drugs.
Report Scope
The Antimania Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antimania Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antimania Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
AstraZeneca
Pfizer
Xian Janssen Pharmaceutical Ltd.
Otsuka Pharmaceutical
Allergan
Segment by Type
Lithium Carbonate
Other
Segment by Application
Children
Teenager
Middle-age
Elder
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antimania Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antimania Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lithium Carbonate
1.2.3 Other
1.3 Market by Application
1.3.1 Global Antimania Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Teenager
1.3.4 Middle-age
1.3.5 Elder
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antimania Drugs Market Perspective (2019-2030)
2.2 Antimania Drugs Growth Trends by Region
2.2.1 Global Antimania Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antimania Drugs Historic Market Size by Region (2019-2024)
2.2.3 Antimania Drugs Forecasted Market Size by Region (2025-2030)
2.3 Antimania Drugs Market Dynamics
2.3.1 Antimania Drugs Industry Trends
2.3.2 Antimania Drugs Market Drivers
2.3.3 Antimania Drugs Market Challenges
2.3.4 Antimania Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antimania Drugs Players by Revenue
3.1.1 Global Top Antimania Drugs Players by Revenue (2019-2024)
3.1.2 Global Antimania Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Antimania Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antimania Drugs Revenue
3.4 Global Antimania Drugs Market Concentration Ratio
3.4.1 Global Antimania Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antimania Drugs Revenue in 2023
3.5 Antimania Drugs Key Players Head office and Area Served
3.6 Key Players Antimania Drugs Product Solution and Service
3.7 Date of Enter into Antimania Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antimania Drugs Breakdown Data by Type
4.1 Global Antimania Drugs Historic Market Size by Type (2019-2024)
4.2 Global Antimania Drugs Forecasted Market Size by Type (2025-2030)
5 Antimania Drugs Breakdown Data by Application
5.1 Global Antimania Drugs Historic Market Size by Application (2019-2024)
5.2 Global Antimania Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antimania Drugs Market Size (2019-2030)
6.2 North America Antimania Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antimania Drugs Market Size by Country (2019-2024)
6.4 North America Antimania Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antimania Drugs Market Size (2019-2030)
7.2 Europe Antimania Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antimania Drugs Market Size by Country (2019-2024)
7.4 Europe Antimania Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antimania Drugs Market Size (2019-2030)
8.2 Asia-Pacific Antimania Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antimania Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Antimania Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antimania Drugs Market Size (2019-2030)
9.2 Latin America Antimania Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antimania Drugs Market Size by Country (2019-2024)
9.4 Latin America Antimania Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antimania Drugs Market Size (2019-2030)
10.2 Middle East & Africa Antimania Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antimania Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Antimania Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Antimania Drugs Introduction
11.1.4 Eli Lilly and Company Revenue in Antimania Drugs Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Antimania Drugs Introduction
11.2.4 AstraZeneca Revenue in Antimania Drugs Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Antimania Drugs Introduction
11.3.4 Pfizer Revenue in Antimania Drugs Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Xian Janssen Pharmaceutical Ltd.
11.4.1 Xian Janssen Pharmaceutical Ltd. Company Detail
11.4.2 Xian Janssen Pharmaceutical Ltd. Business Overview
11.4.3 Xian Janssen Pharmaceutical Ltd. Antimania Drugs Introduction
11.4.4 Xian Janssen Pharmaceutical Ltd. Revenue in Antimania Drugs Business (2019-2024)
11.4.5 Xian Janssen Pharmaceutical Ltd. Recent Development
11.5 Otsuka Pharmaceutical
11.5.1 Otsuka Pharmaceutical Company Detail
11.5.2 Otsuka Pharmaceutical Business Overview
11.5.3 Otsuka Pharmaceutical Antimania Drugs Introduction
11.5.4 Otsuka Pharmaceutical Revenue in Antimania Drugs Business (2019-2024)
11.5.5 Otsuka Pharmaceutical Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Antimania Drugs Introduction
11.6.4 Allergan Revenue in Antimania Drugs Business (2019-2024)
11.6.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antimania Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Lithium Carbonate
Table 3. Key Players of Other
Table 4. Global Antimania Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antimania Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antimania Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antimania Drugs Market Share by Region (2019-2024)
Table 8. Global Antimania Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antimania Drugs Market Share by Region (2025-2030)
Table 10. Antimania Drugs Market Trends
Table 11. Antimania Drugs Market Drivers
Table 12. Antimania Drugs Market Challenges
Table 13. Antimania Drugs Market Restraints
Table 14. Global Antimania Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antimania Drugs Market Share by Players (2019-2024)
Table 16. Global Top Antimania Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimania Drugs as of 2023)
Table 17. Ranking of Global Top Antimania Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antimania Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antimania Drugs Product Solution and Service
Table 21. Date of Enter into Antimania Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antimania Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antimania Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Antimania Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antimania Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Antimania Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antimania Drugs Revenue Market Share by Application (2019-2024)
Table 29. Global Antimania Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antimania Drugs Revenue Market Share by Application (2025-2030)
Table 31. North America Antimania Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antimania Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antimania Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antimania Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antimania Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antimania Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antimania Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antimania Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antimania Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antimania Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antimania Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antimania Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antimania Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antimania Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antimania Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Eli Lilly and Company Company Detail
Table 47. Eli Lilly and Company Business Overview
Table 48. Eli Lilly and Company Antimania Drugs Product
Table 49. Eli Lilly and Company Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 50. Eli Lilly and Company Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Antimania Drugs Product
Table 54. AstraZeneca Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Antimania Drugs Product
Table 59. Pfizer Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Xian Janssen Pharmaceutical Ltd. Company Detail
Table 62. Xian Janssen Pharmaceutical Ltd. Business Overview
Table 63. Xian Janssen Pharmaceutical Ltd. Antimania Drugs Product
Table 64. Xian Janssen Pharmaceutical Ltd. Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 65. Xian Janssen Pharmaceutical Ltd. Recent Development
Table 66. Otsuka Pharmaceutical Company Detail
Table 67. Otsuka Pharmaceutical Business Overview
Table 68. Otsuka Pharmaceutical Antimania Drugs Product
Table 69. Otsuka Pharmaceutical Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 70. Otsuka Pharmaceutical Recent Development
Table 71. Allergan Company Detail
Table 72. Allergan Business Overview
Table 73. Allergan Antimania Drugs Product
Table 74. Allergan Revenue in Antimania Drugs Business (2019-2024) & (US$ Million)
Table 75. Allergan Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antimania Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antimania Drugs Market Share by Type: 2023 VS 2030
Figure 3. Lithium Carbonate Features
Figure 4. Other Features
Figure 5. Global Antimania Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antimania Drugs Market Share by Application: 2023 VS 2030
Figure 7. Children Case Studies
Figure 8. Teenager Case Studies
Figure 9. Middle-age Case Studies
Figure 10. Elder Case Studies
Figure 11. Antimania Drugs Report Years Considered
Figure 12. Global Antimania Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Antimania Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Antimania Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Antimania Drugs Market Share by Players in 2023
Figure 16. Global Top Antimania Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimania Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Antimania Drugs Revenue in 2023
Figure 18. North America Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Antimania Drugs Market Share by Country (2019-2030)
Figure 20. United States Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antimania Drugs Market Share by Country (2019-2030)
Figure 24. Germany Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antimania Drugs Market Share by Region (2019-2030)
Figure 32. China Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antimania Drugs Market Share by Country (2019-2030)
Figure 40. Mexico Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antimania Drugs Market Share by Country (2019-2030)
Figure 44. Turkey Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Antimania Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Eli Lilly and Company Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 47. AstraZeneca Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 49. Xian Janssen Pharmaceutical Ltd. Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 50. Otsuka Pharmaceutical Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 51. Allergan Revenue Growth Rate in Antimania Drugs Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
